Athersys, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

ATHX 2.00 +0.14 (7.53%)
price chart
Athersys Inc. (ATHX) Soars 7.53% on November 22
Athersys Inc. (ATHX) had a good day on the market for Wednesday November 22 as shares jumped 7.53% to close at $2.00. About 1.18 million shares traded hands on 3,953 trades for the day, compared with an average daily volume of 1.02 million shares ...
Athersys, Inc. (ATHX) Upgraded by ValuEngine to Hold  Dispatch Tribunal
Athersys, Inc. (ATHX) Rating Increased to Hold at ValuEngine  StockNewsTimes
Athersys Earnings - Anticipation Builds For A Partnership
Athersys Inc. (ATHX) is a clinical stage biotechnology company pioneering its human stem cell therapy, MultiStem, in multiple applications including ischemic stroke - ongoing Phase III, Phase II acute myocardial infarction [AMI], Phase II acute ...
Have Experts Now Turned Bearish On Pepsico, Inc. (PEP), Athersys, Inc. (ATHX)?
Pepsico, Inc. (NYSE:PEP) recently ticked higher on weak volume. About 3.18 million contracts were traded on 21-Nov-17 compared to daily average volume of 3.67 million shares.
Athersys, Inc. (NasdaqCM:ATHX): What's Inside the Numbers
After a recent scan, we can see that Athersys, Inc. (NasdaqCM:ATHX) has a Shareholder Yield of -34.04% and a Shareholder Yield (Mebane Faber) of -38.64%.
The long-Term Viability Of International, Ltd. (CTRP), Athersys, Inc ...
Volume for International, Ltd. (NASDAQ:CTRP) decreased on 11/20/17 and the net result is a -0.8 fall from the open. The stock closed with a volume of 3.24 million shares (lighter than the 3-month average volume of 5.15 million shares per day.
Short Term Technical Outlook: Athersys, Inc. (ATHX), CenturyLink, Inc. (CTL)
Athersys, Inc. (NASDAQ:ATHX) traded at an unexpectedly low level on 11/13/2017 when the stock experienced a -0.53% loss to a closing price of $1.86.
Analyst's Take on Athersys Inc (ATHX) and Lumber Liquidators Holdings ...  Post Registrar
Securities Analyst Recommendations: Athersys, Inc. (ATHX), Keysight ...  Analyst Journal
Analysts Suggest There's Still Momentum for Athersys, Inc. (ATHX), Wayfair Inc ...
Athersys, Inc. (NASDAQ:ATHX) recent rally took place on significantly less volume which dipped to nearly 0.43 million contracts on 16-Nov-17 versus its daily average of 1.17 million.
Analyzing Analyst Recommendations: Athersys, Inc. (ATHX), Liberty ...  Analyst Journal
Athersys, Inc. (NASDAQ:ATHX) Holdings Increased by Schwab Charles Investment ...  The Ledger Gazette
Are Firms & Funds Taking More Interest in Athersys, Inc. (NASDAQ:ATHX)?
In the SEC's latest filings, institutions owning shares of Athersys, Inc. (NASDAQ:ATHX) have increased their transactions by 11.98%.
Analyst Hints Surrounding Eagle Pharmaceuticals, Inc. (EGRX) And Athersys, Inc ...
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) traded at an unexpectedly low level on 11/03/2017 when the stock experienced a 3.29% gain to a closing price of $55.32.
Two Stocks To Trade Now: Eagle Pharmaceuticals, Inc. (EGRX), Athersys, Inc ...  Analyst Journal
The Athersys Inc. (ATHX) Upgrade to “Strong-Buy” by The Zacks Investment ...  BangaloreWeekly
Japanese study involving Athersys' MultiStem technology has enrolled its first ...
Cleveland biotechnology company Athersys Inc. (Nasdaq: ATHX) announced that Healios K.K., its partner in Japan, has enrolled the first patient in a study evaluating MultiStem cell therapy treatment of patients who have suffered an ischemic stroke ...
HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of ...  Markets Insider
Athersys Gets a Buy Rating from Maxim Group  Analyst Ratings